Touchstone International Medical Science Co., Ltd. (SHA:688013)
China flag China · Delayed Price · Currency is CNY
43.15
+0.33 (0.77%)
Feb 13, 2026, 3:00 PM CST

SHA:688013 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
314.08272.34253.6231.73213.74163.34
Other Revenue
0.030.030.040.3100
314.11272.37253.65232.03213.74163.34
Revenue Growth (YoY)
14.63%7.38%9.31%8.56%30.85%-5.45%
Cost of Revenue
118.85113.64111.899.891.2768.25
Gross Profit
195.27158.73141.85132.23122.4795.09
Selling, General & Admin
82.3274.6671.961.6662.3748.47
Research & Development
40.0735.9935.3234.7529.2815.37
Other Operating Expenses
1.91.794.752.392.131.35
Operating Expenses
124.46112.38112.2798.9794.0565.27
Operating Income
70.846.3429.5833.2728.4129.82
Interest Expense
-0.28-0.23-0.09-0.16--
Interest & Investment Income
6.089.128.034.7611.152.26
Currency Exchange Gain (Loss)
-0.01-0.012.473.9441.8
Other Non Operating Income (Expenses)
10.85-0.171.89-0.12-0.06-0.09
EBT Excluding Unusual Items
87.4455.0641.8841.6943.5133.79
Gain (Loss) on Sale of Investments
-0.13-1.894.062.090.440.56
Gain (Loss) on Sale of Assets
-0-000.020.52-0
Asset Writedown
-0.01-----
Legal Settlements
-----1.08-
Other Unusual Items
1.661.662.012.282.715.85
Pretax Income
88.9754.8347.9546.0846.0940.2
Income Tax Expense
7.882.940.642.894.675.25
Net Income
81.0951.8947.3143.241.4234.95
Net Income to Common
81.0951.8947.3143.241.4234.95
Net Income Growth
42.38%9.69%9.53%4.29%18.52%-16.80%
Shares Outstanding (Basic)
798079808065
Shares Outstanding (Diluted)
818182828165
Shares Change (YoY)
1.54%-0.60%0.09%0.35%25.49%7.85%
EPS (Basic)
1.020.650.600.540.520.54
EPS (Diluted)
1.000.640.580.530.510.54
EPS Growth
40.22%10.35%9.43%3.92%-5.56%-22.86%
Free Cash Flow
13.4511.4764.542.7351.7734.79
Free Cash Flow Per Share
0.170.140.790.030.640.54
Dividend Per Share
0.5001.000-0.2500.2000.200
Dividend Growth
---25.00%--
Gross Margin
62.16%58.28%55.92%56.99%57.30%58.22%
Operating Margin
22.54%17.02%11.66%14.34%13.29%18.25%
Profit Margin
25.81%19.05%18.65%18.62%19.38%21.39%
Free Cash Flow Margin
4.28%4.21%25.44%1.18%24.22%21.30%
EBITDA
80.155.5338.6341.3535.6436.36
EBITDA Margin
25.50%20.39%15.23%17.82%16.67%22.26%
D&A For EBITDA
9.299.199.058.097.226.54
EBIT
70.846.3429.5833.2728.4129.82
EBIT Margin
22.54%17.02%11.66%14.34%13.29%18.25%
Effective Tax Rate
8.86%5.36%1.33%6.27%10.14%13.07%
Revenue as Reported
314.11272.37253.65232.03213.74163.34
Source: S&P Global Market Intelligence. Standard template. Financial Sources.